Company: GANX
Filing Date: 2025-10-14
Form Type: 8-K
Source: 0001104659-25-099343
Chunk: 1

Company: Gain Therapeutics, Inc.
Filing Date: 2025-10-14
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  99.1      Presentation                                                  
   104      Cover Page Interactive Data File (embedded within the Inline  

SIGNATURE

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                              GAIN THERAPEUTICS, INC.                               
  Date: October 14, 2025      By:                          /s/ Gene Mack            
                              Name:                        Gene Mack                
                              Title:                       Chief Executive Officer